Granzyme B-PET: Predicting Immunotherapy Efficacy in TNBC

Clinical trial NCT07705438 · RECRUITING

Trial details

NCT number: NCT07705438
Sponsor: Fudan University
Status: RECRUITING
Study type: OBSERVATIONAL

Triple Negative Breast Cancer Immune Checkpoint Inhibitor Granzyme B PET/CT

Start date: 2025-05-28
Primary completion: 2027-05-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.